Technology
Health
Pharmaceutical

Clementia

$26.00
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.09 (0.35%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Clementia and other stocks, options, ETFs, and crypto commission-free!

About

Clementia Pharmaceuticals Inc. Common Shares, also called Clementia, is a biopharmaceutical company, which focuses on exploiting the science of novel retinoic acid receptor gamma agonists to address bone disease and involves in development and commercialization of treatments for people living with rare diseases. Read More Clementia Pharmaceuticals was founded by Clarissa Desjardins and Jean-Claude Tardif on November 5, 2010 and is headquartered in Montreal, Canada.

Employees
30
Headquarters
Montréal, Québec
Founded
2010
Market Cap
824.66M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
114.99K
High Today
$26.09
Low Today
$25.86
Open Price
$25.86
Volume
85.71K
52 Week High
$26.57
52 Week Low
$8.10

Collections

Technology
Health
Pharmaceutical
Healthcare
Biopharmaceutical
2017 IPO
Canada
North America

Earnings

-$3.88
-$2.69
-$1.51
-$0.32
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
-$0.44 per share
Actual
Expected Mar 27, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.